title: Fibromyalgia · anxiety/depression · urinary retention · Dx?
authors.affiliation: Centro de Salud de BenifaiÓ, Departamento de Salud de la Ribera, Valencia, Spain. Email: p.rothdamas@gmail.com.
authors.forename: Patricia
authors.initials: P
authors.lastname: Roth-Damas
authors.affiliation: Centro de Salud de Algemesí, Departamento de Salud de la Ribera, Valencia, Spain.
authors.forename: Mara
authors.initials: M
authors.lastname: Sempere-Manuel
authors.affiliation: Hospital de la Ribera, SubdirecciÓn Asistencial, Departamento de Salud de la Ribera, Valencia, Spain.
authors.forename: Vicente
authors.initials: V
authors.lastname: Palop-Larrea
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects* / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005356:Fibromyalgia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016055:Urinary Retention / Q000139:chemically induced* / Q000150:complications
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000639:Amitriptyline